CN101716158A - Method for preparing matrine slow-release tablet by applying attapulgite - Google Patents

Method for preparing matrine slow-release tablet by applying attapulgite Download PDF

Info

Publication number
CN101716158A
CN101716158A CN201010100897A CN201010100897A CN101716158A CN 101716158 A CN101716158 A CN 101716158A CN 201010100897 A CN201010100897 A CN 201010100897A CN 201010100897 A CN201010100897 A CN 201010100897A CN 101716158 A CN101716158 A CN 101716158A
Authority
CN
China
Prior art keywords
matrine
attapulgite
slow
release tablet
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201010100897A
Other languages
Chinese (zh)
Other versions
CN101716158B (en
Inventor
尹秀莲
游庆红
固旭
赵玉萍
吴洁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huaiyin Institute of Technology
Original Assignee
Huaiyin Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huaiyin Institute of Technology filed Critical Huaiyin Institute of Technology
Priority to CN2010101008977A priority Critical patent/CN101716158B/en
Publication of CN101716158A publication Critical patent/CN101716158A/en
Application granted granted Critical
Publication of CN101716158B publication Critical patent/CN101716158B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a method for preparing matrine slow-release tablets by applying attapulgite, which comprises the following steps of: dissolving matrine by using hydrochloric acid with the mass concentration of 0.1 percent to obtain 2-5mg/ml of matrine solution; adsorbing the matrine solution through modified attapulgite for 4-6 hours according to the proportion by weight of 1:2; filtering and drying to obtain the attapulgite loading the matrine; and adding 2 percent by weight of talcum powder into the attapulgite loading the matrine, granulating by a dry method, and tabletting to obtain the matrine slow-release tablets. A modifying method of the attapulgite comprises the following steps of: weighing 20g of attapulgite, placing the attapulgite into 1000ml of aqueous solution, stirring for 12 hours, settling, removing upper water, adding purified water, stirring for 12 hours, settling, taking an intermediate fine particle layer, adding concentrated hydrochloric acid, settling for 24 hours, filtering through suction, washing with water to be neutral, drying at the temperature of 105DEG C, finely grinding and screening with a 120-mesh screen to obtain acid modified attapulgite. The invention adopts the principle of adsorption separation and selects the modified attapulgite which can be taken as an adsorbent for adsorbing the matrine, the matrine slow-release tablets are slowly released under the desorption action of a body fluid, operation steps are simple, and the production period of traditional Chinese medicine preparations is shortened.

Description

A kind of method of preparing matrine slow-release tablet by applying attapulgite
Technical field
The present invention relates to the preparation method of oral sustained release sheet, be specifically related to a kind of method of preparing matrine slow-release tablet by applying attapulgite.
Background technology
Matrine is the tetracyclic quinolizidine kind alkaloid that comes out from separation such as leguminous plant Radix Sophorae Flavescentis Herba Sophorae alopecuroidis, root of subprostrate sophoras, has to suppress hepatitis B HbeAg and duplicate, improve pharmacological actions such as pathologic hepatitis symptom and sign, anticancer, arrhythmia, anti-hepatic fibrosis, immunosuppressant, antiinflammatory, resisting hypertension vascular remodeling.The matrine preparation of clinical use is based on injection, and it is short that it eliminates the half-life, if make ordinary tablet, need oral 3~4 times every day, and " peak valley " phenomenon can appear in the back blood drug level of taking medicine, and side effect is increased, curative effect reduces, and brings inconvenience for treatment and patient.The patent of Granted publication CN1235584C " matrine slow-release tablet and preparation method thereof ", publication number is the patent " matrine oral sustained release sheet and preparation method thereof " of CN1555797A, the preparation method of matrine slow-release tablet is all disclosed, method therefor all is the slow releasing preparation common method, adopt the rate of release of sustained-release matrix host material control active component commonly used, reach the slow release purpose, the used adjuvant complexity of this technology, cost height.
Attapulgite shows good adsorption because of having bigger specific surface area, can be used for multiple field.The modification of attapulgite can make structure charge and the surface charge of attapulgite in aqueous solution change, can improve its specific surface area even change its structure, improve the specific surface area of attapulgite, thereby absorption property improves greatly, is applicable to the separation of active component in the Chinese medicine extraction liquid.The research of attapulgite oral formulations has had very deep research, and applied research shows its safety non-toxic, is fit to be applied to pharmaceutical preparation.
Summary of the invention
The objective of the invention is to: a kind of method of preparing matrine slow-release tablet by applying attapulgite is provided, and this preparation method can shorten the production cycle, reduces production costs, and improves the added value of attapulgite, reaches the preparation slow release simultaneously, satisfies the requirement of clinical application.
Technical solution of the present invention is that this preparation method may further comprise the steps:
(1), gets the matrine solution of 2~5mg/ml with the dissolving with hydrochloric acid matrine of mass concentration 0.1%;
(2) matrine solution filters through attapulgite modified absorption 4~6h, dries, and obtains the attapulgite of load matrine;
(3) add pharmaceutic adjuvant in the attapulgite of load matrine, dry granulation, tabletting get matrine slow-release tablet.
Wherein, the attapulgite modified of (2) step employing is that acid is attapulgite modified, and the method for modifying of described attapulgite is: take by weighing attapulgite 20g and place the 1000ml aqueous solution, stir 12h, leave standstill, remove upper water, add pure water, stir 12h, leave standstill, the fine grained layer adds concentrated hydrochloric acid and leaves standstill 24h, sucking filtration in the middle of getting, be washed to neutrality, 105 ℃ of dryings, porphyrize, cross 120 mesh sieves, it is attapulgite modified to obtain acid.
Wherein, sour attapulgite modified and weight ratio matrine of (2) step employing is 2: 1.
Wherein, (3) step was added the Pulvis Talci of its weight 2% in the attapulgite of load matrine.
The present invention has the following advantages: 1, matrine slow-release tablet coating or adopt coating material coating, even, bright and clean, the invariant color of the product color of dry granulation tabletting gained not; 2, this method is attapulgite modified to the matrine selective absorption by acid, and the absorption back is the preparation tablet directly, oral entering in the body, and matrine can discharge from attapulgite under the desorption of body fluid slowly, thereby reaches the effect of slow release; 3, this preparation method is with short production cycle, and production cost is low, has improved the added value of attapulgite, and the preparation slow release satisfies the requirement of clinical application simultaneously.
Description of drawings
Fig. 1 is the release curve of the matrine slow-release tablet of embodiment 1
Fig. 2 is the release curve of the matrine slow-release tablet of embodiment 2
Fig. 3 is the release curve of the matrine slow-release tablet of embodiment 3
The specific embodiment
Below by specific embodiment technical scheme of the present invention is further described, can not be interpreted as that these embodiment are the restrictions to technical scheme.
Embodiment 1: take by weighing attapulgite 20g and place the 1000ml aqueous solution, stir 12h, leave standstill, remove upper water, add pure water, stir 12h, leave standstill, the fine grained layer adds concentrated hydrochloric acid and leaves standstill 24h in the middle of getting, sucking filtration, be washed to neutrality, 105 ℃ of dryings, porphyrize, cross 120 mesh sieves, it is attapulgite modified to obtain acid; Get matrine 20g, become the solution of 2mg/ml with the dissolving with hydrochloric acid of mass concentration 0.1%; With matrine solution through the attapulgite modified absorption 4h of 40g acid, filtration, 60 ℃ of vacuum dryings obtain the attapulgite of load matrine; In the attapulgite of load matrine, add the Pulvis Talci mix homogeneously of its weight 2%, dry granulation, the granulate that sieves, tabletting is made 100 altogether.
Embodiment 2: take by weighing attapulgite 20g and place the 1000ml aqueous solution, stir 12h, leave standstill, remove upper water, add pure water, stir 12h, leave standstill, the fine grained layer adds concentrated hydrochloric acid and leaves standstill 24h in the middle of getting, sucking filtration, be washed to neutrality, 105 ℃ of dryings, porphyrize, cross 120 mesh sieves, it is attapulgite modified to obtain acid; Get matrine 40g, become the solution of 3mg/ml with the dissolving with hydrochloric acid of mass concentration 0.1%; With matrine solution through the attapulgite modified absorption 5h of 80g acid, filtration, 60 ℃ of vacuum dryings obtain the attapulgite of load matrine; In the attapulgite of load matrine, add the Pulvis Talci mix homogeneously of its weight 2%, dry granulation, the granulate that sieves, tabletting is made 200 altogether.
Embodiment 3: take by weighing attapulgite 20g and place the 1000ml aqueous solution, stir 12h, leave standstill, remove upper water, add pure water, stir 12h, leave standstill, the fine grained layer adds concentrated hydrochloric acid and leaves standstill 24h in the middle of getting, sucking filtration, be washed to neutrality, 105 ℃ of dryings, porphyrize, cross 120 mesh sieves, it is attapulgite modified to obtain acid; Get matrine 40g, become the solution of 5mg/ml with the dissolving with hydrochloric acid of mass concentration 0.1%; With matrine solution through the attapulgite modified absorption 6h of 80g acid, filtration, 60 ℃ of vacuum dryings obtain the attapulgite of load matrine; In load matrine sour attapulgite modified, add the Pulvis Talci mix homogeneously of its weight 2%, dry granulation, the granulate that sieves, tabletting is made 200 altogether.
Assay: get slow releasing tablet a slice, grind, place to add 50ml methanol eddy extraction 2h in the boiling flask, extracting liquid filtering is collected filtrate, filters through 0.45 μ m microporous filter membrane, and employing is that the high performance liquid chromatography of reference substance is carried out assay with the matrine.
Drug release determination: according to " 2005 editions two appendix XD first methods of Chinese pharmacopoeia, the device of employing dissolution method first method carries out the mensuration of release; The release curve of embodiment 1-3 gained matrine slow-release tablet respectively as Figure 1-3.

Claims (4)

1. the method for a preparing matrine slow-release tablet by applying attapulgite is characterized in that this preparation method may further comprise the steps:
(1), gets the matrine solution of 2~5mg/ml with the dissolving with hydrochloric acid matrine of mass concentration 0.1%;
(2) matrine solution filters through attapulgite modified absorption 4~6h, dries, and obtains the attapulgite of load matrine;
(3) add pharmaceutic adjuvant in the attapulgite of load matrine, dry granulation, tabletting get matrine slow-release tablet.
2. the method for a kind of preparing matrine slow-release tablet by applying attapulgite according to claim 1, it is characterized in that: it is attapulgite modified for sour attapulgite modified that (2) step adopted, the method of modifying of described attapulgite is: take by weighing attapulgite 20g and place the 1000ml aqueous solution, stir 12h, leave standstill, remove upper water, add pure water, stir 12h, leave standstill, the fine grained layer adds concentrated hydrochloric acid and leaves standstill 24h in the middle of getting, sucking filtration, be washed to neutrality, 105 ℃ of dryings, porphyrize, cross 120 mesh sieves, it is attapulgite modified to obtain acid.
3. the method for a kind of preparing matrine slow-release tablet by applying attapulgite according to claim 2 is characterized in that: sour attapulgite modified and weight ratio matrine that (2) step adopted is 2: 1.
4. the method for a kind of preparing matrine slow-release tablet by applying attapulgite according to claim 1 is characterized in that: the Pulvis Talci of (3) step its weight 2% of interpolation in the attapulgite of load matrine.
CN2010101008977A 2010-01-25 2010-01-25 Method for preparing matrine slow-release tablet by applying attapulgite Expired - Fee Related CN101716158B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010101008977A CN101716158B (en) 2010-01-25 2010-01-25 Method for preparing matrine slow-release tablet by applying attapulgite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010101008977A CN101716158B (en) 2010-01-25 2010-01-25 Method for preparing matrine slow-release tablet by applying attapulgite

Publications (2)

Publication Number Publication Date
CN101716158A true CN101716158A (en) 2010-06-02
CN101716158B CN101716158B (en) 2011-06-15

Family

ID=42430855

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010101008977A Expired - Fee Related CN101716158B (en) 2010-01-25 2010-01-25 Method for preparing matrine slow-release tablet by applying attapulgite

Country Status (1)

Country Link
CN (1) CN101716158B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102266308A (en) * 2011-07-27 2011-12-07 淮阴工学院 Method for preparing odor masking sustained-release garlicin composite micro-capsules
CN102552925A (en) * 2012-01-31 2012-07-11 淮阴工学院 Method for preparing alginic acid/attapulgite composite for sustained or controlled release tablets of medicine
CN103251956A (en) * 2013-04-19 2013-08-21 张彩云 Matrine-montmorillonite nano composite and preparation method thereof
CN103749571A (en) * 2013-12-23 2014-04-30 杨立新 Attapulgite sterilization mite suppressor and preparation method thereof
CN106929031A (en) * 2017-03-24 2017-07-07 孙志廷 It is a kind of with broad spectrum disinfestation and the good Nutrition Soil of water retention property and preparation method thereof
CN109549967A (en) * 2018-12-20 2019-04-02 中国农业科学院兰州畜牧与兽药研究所 A kind of sophora alapecuroides slow-releasing granules and preparation method thereof
CN113289024A (en) * 2021-06-07 2021-08-24 明光市铭垚凹凸棒产业科技有限公司 Medicine carrying nano-particles based on attapulgite

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102266308A (en) * 2011-07-27 2011-12-07 淮阴工学院 Method for preparing odor masking sustained-release garlicin composite micro-capsules
CN102266308B (en) * 2011-07-27 2012-10-24 淮阴工学院 Method for preparing odor masking sustained-release garlicin composite micro-capsules
CN102552925A (en) * 2012-01-31 2012-07-11 淮阴工学院 Method for preparing alginic acid/attapulgite composite for sustained or controlled release tablets of medicine
CN102552925B (en) * 2012-01-31 2013-05-22 淮阴工学院 Method for preparing alginic acid/attapulgite composite for sustained or controlled release tablets of medicine
CN103251956A (en) * 2013-04-19 2013-08-21 张彩云 Matrine-montmorillonite nano composite and preparation method thereof
CN103749571A (en) * 2013-12-23 2014-04-30 杨立新 Attapulgite sterilization mite suppressor and preparation method thereof
CN103749571B (en) * 2013-12-23 2016-01-20 杨立新 A kind of attapulgite sterilization mite suppressor and preparation method thereof
CN106929031A (en) * 2017-03-24 2017-07-07 孙志廷 It is a kind of with broad spectrum disinfestation and the good Nutrition Soil of water retention property and preparation method thereof
CN109549967A (en) * 2018-12-20 2019-04-02 中国农业科学院兰州畜牧与兽药研究所 A kind of sophora alapecuroides slow-releasing granules and preparation method thereof
CN113289024A (en) * 2021-06-07 2021-08-24 明光市铭垚凹凸棒产业科技有限公司 Medicine carrying nano-particles based on attapulgite
CN113289024B (en) * 2021-06-07 2024-02-09 明光市铭垚凹凸棒产业科技有限公司 Medicine carrying nano-particle based on attapulgite

Also Published As

Publication number Publication date
CN101716158B (en) 2011-06-15

Similar Documents

Publication Publication Date Title
CN101716158B (en) Method for preparing matrine slow-release tablet by applying attapulgite
CN101580527B (en) Adsorption resin method separation technology of scutellarin in fleabane flower extract
CN102212091A (en) High-purity geniposide as well as preparation and clinical application of preparations thereof
CN102167777B (en) Preparation method and application of molecularly imprinted polymer
CN101343297B (en) Method for extracting and purifying gardenoside with absorbent charcoal
KR20160110369A (en) Drug combination, method of preparing same, and use thereof
KR20160117425A (en) Solid dispersion containing desmodium styracifolium (osb.) merr. flavonoids, method of preparing same, and use thereof
CN101612188B (en) Preparation method and product of eucommia bark depressor Chinese medicament sustained release preparation
CN100477985C (en) Naoxinqing Chinese medicine dispersible tablet and its preparing process
CN101716198A (en) Method for preparing total ginkgo flavone glycosides slow-release capsules by applying attapulgite
CN101129513B (en) Method for preparing crataegutt sustained-release formulation by using separation - formulated product coupling technique
CN101028343B (en) Total alkaloid of meadowrue corydalis and its purification and medicinal composition
CN103372034A (en) Preparation method of ginkgo biloba extract
CN109776515A (en) The method of mangiferin is extracted from myrica rubra leaf
CN105272919B (en) A kind of method that allantoin is prepared in the oligosaccharide syrup from saline cistanche
CN101721449B (en) Method for preparing lindley eupatorium herb general flavone by using attapulgite adsorption method
CN101549010A (en) A preparing method and application of malaytea scurfpea fruit total glycosides extract
CN102885985A (en) Preparation method and application of rhizoma gastrodiae and rhizoma chuanxiong compound extract
CN114570327A (en) Traditional Chinese medicine heavy metal removal method based on novel amino acid modified attapulgite
CN102000126B (en) Ginkgo flavone tablet and preparation method thereof
CN1546124A (en) Freeze-dried 'Shengmai' powder for injection and its preparing process
CN102342963B (en) Preparation process for Gansu soft capsule
CN102911185B (en) Method for separating and purifying ginkgolides A, B, C and D and bilobalide from ginkgo leaf extracts
CN101747402B (en) Method for enriching and purifying malol in sedum kamtschaticum
CN101766683B (en) Salvia dispersible tablet and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110615

Termination date: 20120125